Bayer, Janssen Win Denial Of New Xarelto Trials
A Louisiana federal judge on Tuesday declined to grant new trials to the plaintiffs in the first two bellwether trials in multidistrict litigation alleging Janssen and Bayer's blood thinner Xarelto caused...To view the full article, register now.
Already a subscriber? Click here to view full article